Education

• MD, Duke University School of Medicine, Durham, NC, 1992
• Residency, The Johns Hopkins Hospital, Baltimore, MD, 1992-1999
• Postdoctoral Research Fellowship, The Johns Hopkins Oncology Center, Baltimore, MD, 1994-1997
• Fellowship in Surgical Oncology, The Johns Hopkins Hospital, Baltimore, MD, 1998-2000

Clinical Specialties

Dr. Chen is certified by the American Board of Surgery. He specializes in endocrine surgery (thyroid surgery, minimally invasive parathyroidectomy, and laparoscopic adrenalectomy); minimally invasive endocrine surgery, surgical oncology and adult general surgery.

Dr. Chen provides a wide range of services including Adrenalectomy, Laparoscopic, Adrenalectomy, Open, Adrenal Surgery, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Parathyroid Surgery, Resection Of Substernal Goiter, Subtotal Parathyroidectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, and Total Thyroidectomy.

Research Interests

Dr. Chen is the leader of the endocrine cancer group at the University of Wisconsin Carbone Cancer Center. His research program investigates the development, progression, and treatment of endocrine tumors including gastrointestinal carcinoids, thyroid cancer, adrenal cancer, and pancreatic islet cell tumors.

Dr. Chen's Lab

Funding/Grants

• AAS Courses to Increase Women and Minorities in Academic Surgery
  Funding Agency: National Institutes of Health (NIH)
  Principal Investigator(s): Herbert Chen, MD
  More Information
• GSK3β Signaling in Medullary Thyroid Cancer
  Funding Agency: National Institutes of Health
  Principal Investigator(s): Herbert Chen, MD
  More Information
• MEN2 Thyroid Cancer Professorship
  Funding Agency: American Cancer Society
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Minority Supplement for Yvette Carter
  Funding Agency: NIH/NIC
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Modulating Raf-1 Signaling in Carcinoid Cancer
  Funding Agency: Carcinoid Cancer Foundation
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Phase II Clinical Trial of LBH589 for Gastrointestinal Neuroendocrine Cancers
  Funding Agency: Novartis
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Surgery Summer Experience for Medical Students
  Funding Agency: NIH/NIDDK
  Principal Investigator(s): Herbert Chen, MD
  More Information
• Surgical Oncology Research Training Program
  Funding Agency: National Institutes of Health
  Principal Investigator(s): Herbert Chen, MD
  More Information
• The Role of GSK3β in Carcinoid and Other Neuroendocrine Cancers
  Funding Agency: The Doctors Cancer Foundation
  Principal Investigator(s): Herbert Chen, MD
  More Information

Recent Publications

• The Necessity and Reliability of Intraoperative Parathyroid Hormone (PTH) Testing in Patients with Mild Hyperparathyroidism and PTH Levels in the Normal Range: Reply.
  Alhefdhi A, Chen H
  World J Surg 2012 Feb; 36(2):484-5.
  [PubMed ID: 22173590]
  More Information
• False-negative fine-needle aspiration of thyroid nodules cannot be attributed to sampling error alone.
  Yu XM, Patel PN, Chen H, Sippel RS
  American journal of surgery 2012 Jan 25.
  [PubMed ID: 22284047]
  More Information
• Validation of the "Perrier" Parathyroid Adenoma Location Nomenclature.
  Mazeh H, Stoll SJ, Robbins JB, Sippel RS, Chen H
  World journal of surgery 2012 Jan 21.
  [PubMed ID: 22270982]
  More Information
• Hürthle cell metaplasia on fine-needle aspiration biopsy is not by itself an indication for thyroid surgery.
  Hudak K, Mazeh H, Sippel RS, Chen H
  American journal of surgery 2012 Jan 18.
  [PubMed ID: 22264740]
  More Information
• Breast Radiation Correlates with Side of Parathyroid Adenoma.
  Woll ML, Mazeh H, Anderson BM, Chen H, Sippel RS
  World journal of surgery 2011 Dec 30.
  [PubMed ID: 22207495]
  More Information